Patents by Inventor Daya D. Verma

Daya D. Verma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid and its salts formulation
    Publication number: 20210169854
    Abstract: Disclosed are novel pharmaceutical formulation containing 3?-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2?-hydroxy-[1,1?-biphenyl]-3-carboxylic acid or a pharmaceutically acceptable salt thereof and processes for preparing the same.
    Type: Application
    Filed: September 18, 2020
    Publication date: June 10, 2021
    Inventors: Mangesh Sadashiv Bordawekar, Stephanie Kay Dodd, Cornelius Stephan Harlacher, Jithin K John, Pravin Karmuse, Saran Kumar, Sangeetha Kumari, Vishnu Maremanda, Parthkumar Patel, Kanhaiyalal Patidar, Kapil Patil, Alan Edward Royce, Shaikh Mohsin Shaikh Hamid, Mauro Serratoni, Henricus Lambertus Gerardus Maria Tiemessen, Daya D Verma, Sunita Yadav
  • Topiramate compositions and methods of enhancing its bioavailability
    Patent number: 9744137
    Abstract: The present invention is directed to pharmaceutical compositions that allow for once-daily or alternate day dosage forms of topiramate. The proposed delayed/extended release single dosage form is equivalent to the immediate-release multiple dose daily regimen, and upon administration, provides steady state blood levels of topiramate. Formulations with increased bioavailability and improved pharmacokinetics are disclosed. A once-a-day administration of topiramate is advantageous over the multiple dose regimen both in terms of patient compliance and reduced adverse events, thus providing better treatment of the conditions for which the topiramate is indicated.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: August 29, 2017
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Avinash Nangia, Daya D. Verma, Jules Jacob
  • Solid Pharmaceutical Composition Comprising PI3K-Inhibitor
    Publication number: 20170209455
    Abstract: The application relates to solid pharmaceutical compositions suitable for oral administration, processes for their production and uses of the pharmaceutical compositions.
    Type: Application
    Filed: July 24, 2015
    Publication date: July 27, 2017
    Applicant: Novartis AG
    Inventors: Dipen Desai, Bruno Galli, Rakesh Patel, Manuel Vincente Sanchez-Felix, Frank Hans Seiler, Navnit H. Shah, Daya D. Verma, Toni Widmer, Stefanie Meyer, Raman Iyer, Severine Serreau, Simone Grandolini, Oliver Graner
  • PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS
    Publication number: 20100316712
    Abstract: The invention relates to the improvement in the treatment of certain neural disorders/diseases, such as Parkinson's disease and other motor disorders. The invention relates to drug compositions and dosage forms comprising said drug composition; methods of manufacturing the drug compositions and dosage forms; and methods of treatment, comprising administering the drug composition and dosage form to an individual. In certain embodiments, the drug compositions and dosage forms comprise carbidopa and levodopa in a formulation suitable for once-daily administration.
    Type: Application
    Filed: December 21, 2007
    Publication date: December 16, 2010
    Applicant: Combinatorx, Incorporated
    Inventors: Avinash Nangia, Jules Jacob, James Yeh, Peyman Moslemy, Daya D. Verma, Dinesh K. Haswani, Ze'ev Shaked
  • Dosage forms for movement disorder treatment
    Publication number: 20080299204
    Abstract: The invention relates to the improvement in the treatment of certain neural disorders/diseases, such as Parkinson's disease and other motor disorders. One aspect of the invention relates to drug compositions and dosage forms comprising said drug composition. Another aspect of the invention relates to methods of manufacturing the drug compositions and dosage forms. Another aspect of the invention relates to methods of treatment, comprising administering the drug composition and dosage form to an individual.
    Type: Application
    Filed: June 23, 2006
    Publication date: December 4, 2008
    Applicant: Spherics, Inc.
    Inventors: Avinash Nangia, Jules Jacob, James Yeh, Peyman Moslemy, Daya D. Verma, Dinesh K. Haswani, Ze'ev Shaked
  • Dosage forms for movement disorder treatment
    Publication number: 20080131492
    Abstract: The invention relates to the improvement in the treatment of certain neural disorders/diseases, such as Parkinson's disease and other motor disorders. One aspect of the invention relates to drug compositions and dosage forms comprising said drug composition. Another aspect of the invention relates to methods of manufacturing the drug compositions and dosage forms. Another aspect of the invention relates to methods of treatment, comprising administering the drug composition and dosage form to an individual.
    Type: Application
    Filed: June 22, 2007
    Publication date: June 5, 2008
    Applicant: Spherics, Inc.
    Inventors: Avinash Nangia, Jules Jacob, James Yeh, Peyman Moslemy, Daya D. Verma, Dinesh K. Haswani, Ze'ev Shaked